Group 1: Major Tech Stocks Performance - Major tech stocks showed a positive trend, with Tesla rising by 6.36%, Google by 5.49%, Facebook by 3.37%, Amazon by 2.51%, Apple by 0.83%, Microsoft by 0.6%, and Nvidia by 0.2% [2][3] - The Philadelphia Semiconductor Index surged by 3.66%, with Broadcom increasing over 9%, Micron Technology rising by 6.71%, AMD up by 4.05%, and Intel gaining 3.57% [2][5] Group 2: Novo Nordisk's Clinical Trial Results - Novo Nordisk experienced a significant decline of 6.58%, with shares dropping nearly 10% after the company announced that its drug semaglutide did not meet efficacy targets in late-stage trials for Alzheimer's disease [5][6] - The trials aimed to slow cognitive decline in patients by at least 20%, but no significant improvement was observed among thousands of participants [6][7] Group 3: Nasdaq China Golden Dragon Index - The Nasdaq China Golden Dragon Index rose by 2.56%, with notable individual stock performances including Hesai Technology up over 18%, Canadian Solar near 9%, Baidu up 7.84%, and Bilibili rising by 6.96% [9][10] Group 4: Market Outlook and Predictions - Morgan Stanley's chief U.S. equity strategist, Michael Wilson, expressed optimism about the U.S. stock market, suggesting that the recent downturn may soon end and reaffirming a bullish outlook for next year [11][12] - Wilson predicts the S&P 500 index will rebound to 7,800 points in a year, representing an approximate 18% increase from current levels, driven by a potential interest rate cut cycle by the Federal Reserve and an AI-driven efficiency revolution [12][13] - Goldman Sachs anticipates the Federal Reserve will implement a third consecutive rate cut in December, with further cuts expected in 2026, as inflation trends and labor market cooling provide room for policy easing [12][14]
深夜,全线大涨!中国资产大爆发